Polpharma Biologics Gdansk Facility

In Gdansk, we provide process development and GMP production of clinical and medium-scale commercial materials, supported by QC, QA and project management functions.

Quality is at the heart of Polpharma Biologics commitment to delivering safe and effective medicines to patients.

Early discovery, development and optimization of novel therapeutics at Polpharma Biologics

You will have the opportunity to contribute to modern biotechnology using the latest equipment and most advanced technologies available. Our state-of-the-art biopharmaceutical R&D and manufacturing center in Gdansk is one of the most modern biotechnology centers in Europe, complemented by our new commercial manufacturing facility in Duchnice (near Warsaw), fully operational in 2021 and our early stage research site in Utrecht, Netherlands.

We offer fully integrated biopharmaceutical solutions for microbial products. From tech transfer to clinical supply including drug substance and drug product development and manufacturing for preclinical, clinical and commercial.

Located in the Utrecht Science Park, a hub for education, research, entrepreneurship and healthcare. The state-of-the-art facility focuses on the development of production cell lines for monoclonal antibodies (mAbs) and other proteins (including laboratory scale processes), as well as the generation of New Biological Entities (NBEs).

Our proprietary CHOBC® expression platform allows rapid generation of high-quality cell lines with a completely animal component-free (ACF) process. High-throughput technologies are deployed to increase productivity and achieve the highest titers possible, while minimizing undesired species.

Polpharma Biologics has its own pipeline of biosimilar and novel therapeutics for out-licensing. We are focused on advancing and expanding our product portfolio to increase patient access to these much-needed therapies and are open to partnering with other organizations to co-develop or commercialize our biosimilars or novel therapeutics.